Radiopharm’s Share Ownership Highly Concentrated

Radiopharm Theranostics Limited (AU:RAD) has released an update.

Radiopharm Theranostics Limited reports a consolidated shareholder base with 143 holders controlling 99.68% of the issued share capital, reflecting a significant concentration of ownership. The top 20 holders, including major entities such as CITICORP NOMINEES PTY LIMITED and UBS NOMINEES PTY LTD, collectively hold a dominant percentage of the company’s shares, with CITICORP alone accounting for 35.45%.

For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.